Eukaryotic Initiation Factors (eIF) 2α and 4E expression, localization, and phosphorylation in brain tumors

Journal of Histochemistry and Cytochemistry

Volumn 57, Issue 5, 2009, Pages 503-512

  Tejada, Sonia ^a   Lobo, M Val T ^b   García Villanueva, Mercedes ^a   Sacristán, Silvia ^a   Pérez Morgado, M Isabel ^a   Salinas, Matilde ^a   Martín, M Elena ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Brain tumors; Cyclin D1; Eukaryotic translation initiation factor 2 ; Eukaryotic translation initiation factor 4E; Translation

Indexed keywords

CYCLIN D1; INITIATION FACTOR 2ALPHA; INITIATION FACTOR 4E; KI 67 ANTIGEN; PROTEIN P53; INITIATION FACTOR 2; TUMOR MARKER;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TISSUE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; METASTASIS; NEURINOMA; OLIGODENDROGLIOMA; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; BRAIN TUMOR; CELL PROLIFERATION; METABOLISM; MIDDLE AGED; PATHOLOGY;

EUKARYOTA;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CELL PROLIFERATION; CYCLIN D1; EUKARYOTIC INITIATION FACTOR-2; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PHOSPHORYLATION; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 66149125713     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.2009.952929     Document Type: Article

References (48)

1. Alama A, Barbieri F, Spaziante R, Bruzzo C, Dadati P, Dorcaratto A, Ravetti JL (2007) Significance of cyclin D1 expression in meningiomas: a preliminary study. J Clin Neurosci 14:355-358
2. Arnold A, Papanikolaou A (2005) Cyclin D1 in breast cancer pathogenesis. J Clin Oncol 23:4215-4224
3. Biernat W, Kleihues P, Yonekawa Y, Ohgaki H (1997) Amplification and overexpression of MDM2 in primary (de novo) glioblastomas. J Neuropathol Exp Neurol 56:180-185
4. Bouvier-Labit C, Chinot O, Ochi C, Gambarelli D, Dufour H, Figarella-Branger D (1998) Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas. Neuropathol Appl Neurobiol 24:381-388
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
6. Cavalla P, Dutto A, Piva R, Richiardi P, Grosso R, Schiffer D (1998) Cyclin D1 expression in gliomas. Acta Neuropathol 95:131-135
7. Chakrabarty A, Bridges LR, Gray S (1996) Cyclin D1 in astrocytic tumours: an immunohistochemical study. Neuropathol Appl Neurobiol 22:311-316
8. Clemens MJ, Bommer UA (1999) Translational control: the cancer connection. Int J Biochem Cell Biol 31:1-23
9. Culjkovic B, Topisirovic I, Borden KL (2007) Controlling gene expression through RNA regulons: the role of the eukaryotic translation initiation factor eIF4E. Cell Cycle 6:65-69
10. Culjkovic B, Topisirovic I, Skrabanek L, Ruiz-Gutierrez M, Borden KLB (2005) eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3′UTR. J Cell Biol 169:245-256
11. De Benedetti A, Graff JR (2004) eIF-4E expression and its role in malignancies and metastases. Oncogene 23:3189-3199
12. Dever TE (2002) Gene-specific regulation by general translation factors. Cell 108:545-556
13. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG (2004) Minireview: cyclin D1: normal and abnormal functions. Endocrinology 145: 5439-5447
14. Gebauer F, Hentze MW (2004) Molecular mechanisms of translational control. Nat Rev Mol Cell Biol 5:827-835
15. Gu X, Jones L, Lowery-Norberg M, Fowler M (2005) Expression of eukaryotic initiation factor 4E in astrocytic tumors. Appl Immunohistochem Mol Morphol 13:178-183
16. Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M, Ron D (2000) Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 6: 1099-1108
17. Holcik M, Sonenberg N (2005) Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 6:318-327
18. Hunter T, Pines J (1994) Cyclins and cancer. II: cyclin D and CDK inhibitors come of age. Cell 79:573-582
19. Keene JD (2007) RNA regulons: coordination of post-transcriptional events. Nat Rev Genet 8:533-543
20. Kim SH, Gunnery S, Choe JK, Mathews MB (2002) Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR. Oncogene 21:8741-8748
21. Koromilas AE, Roy S, Barber GN, Katze MG, Sonenberg N (1992) Malignant transformation by amutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257:1685-1689
22. Lanzafame S, Torrisi A, Barbagallo G, Emmanuele C, Alberio N, Albanese V (2000) Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up. Pathol Res Pract 196: 483-488
23. Lobo MV, Arenas MI, Alonso FJ, Gomez G, Bazan E, Paino CL, Fernandez E, et al. (2004) Nestin, a neuroectodermal stem cell marker molecule, is expressed in Leydig cells of the human testis and in some specific cell types from human testicular tumours. Cell Tissue Res 316:369-376
24. Lobo MV, Martin ME, Perez MI, Alonso FJ, Redondo C, Alvarez MI, Salinas M (2000) Levels, phosphorylation status and cellular localization of translational factor eIF2 in gastrointestinal carcinomas. Histochem J 32:139-150
25. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHO Classification of Tumours of the Central Nervous System. Lyon, IARC Press
26. Martin ME, Munoz FM, Salinas M, Fando JL (2000a) Ischaemia induces changes in the association of the binding protein 4E-BP1 and eukaryotic initiation factor (eIF) 4G to eIF4E in differentiated PC12 cells. Biochem J 351:327-334
27. Martin ME, Perez MI, Redondo C, Alvarez MI, Salinas M, Fando JL (2000b) 4E binding protein 1 expression is inversely correlated to the progression of gastrointestinal cancers. Int J Biochem Cell Biol 32:633-642
28. Matsumoto K, Suzuki SO, Fukui M, Iwaki T (2004) Accumulation of MDM2 in pleomorphic xanthoastrocytomas. Pathol Int 54: 387-391
29. Milenkovic S, Marinkovic T, Jovanovic MB, Djuricic S, Berisavac II, Berisavac I (2008) Cyclin D1 immunoreactivity in meningiomas. Cell Mol Neurobiol 28:907-913
30. Phillips A, Blaydes JP (2008) MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA. Oncogene 27:1645-1649
31. Raught B, Gingras AC, James A, Medina D, Sonenberg N, Rosen JM (1996) Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells. Cancer Res 56:4382-4386
32. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53:2736-2739
33. Reis RM, Konu-Lebleblicioglu D, Lopes JM, Kleihues P, Ohgaki H (2000) Genetic profile of gliosarcomas. Am J Pathol 156:425-432
34. Rosenwald IB (2004) The role of translation in neoplastic transformation from a pathologist's point of view. Oncogene 23:3230-3247
35. Rosenwald IB, Hutzler MJ, Wang S, Savas L, Fraire AE (2001) Expression of eukaryotic translation initiation factors 4E and 2alpha is increased frequently in bronchioloalveolar but not in squamous cell carcinomas of the lung. Cancer 92:2164-2171
36. Rousseau D, Kaspar R, Rosenwald I, Gehrke L, Sonenberg N (1996) Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc Natl Acad Sci USA 93:1065-1070
37. Scheper GC, Proud CG (2002) Does phosphorylation of the capbinding protein eIF4E play a role in translation initiation? Eur J Biochem 269:5350-5359
38. Schneider R, Sonenberg N (2007) Translational control in cancer development and progression. In Matthews MB, Sonengerg N, Hershey JWB, eds. Translational Control in Biology and Medicine. New York, Cold Spring Harbor Laboratory Press, 401-431
39. Silva RL, Wendel HG (2008) MNK, EIF4E and targeting translation for therapy. Cell Cycle 7:553-555
40. Strudwick S, Borden KL (2002) The emerging roles of translation factor eIF4E in the nucleus. Differentiation 70:10-22
41. Takei H, Bhattacharjee MB, Rivera A, Dancer Y, Powell SZ (2007) New immunohistochemical markers in the evaluation of central nervous system tumors: a review of 7 selected adult and pediatric brain tumors. Arch Pathol Lab Med 131:234-241
42. Topisirovic I, Ruiz-Gutierrez M, Borden KL (2004) Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities. Cancer Res 64:8639-8642
43. Vattem KM, Wek RC (2004) Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci USA 101:11269-11274
44. Wang S, Lloyd RV, HutzlerMJ, Rosenwald IB, Safran MS, Patwardhan NA, Khan A (2001) Expression of eukaryotic translation initiation factors 4E and 2alpha correlates with the progression of thyroid carcinoma. Thyroid 11:1101-1107
45. Wang S, Rosenwald IB, Hutzler MJ, Pihan GA, Savas L, Chen JJ, Woda BA (1999) Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas. Am J Pathol 155:247-255
46. Wendel HG, Silva RL,Malina A,Mills JR, Zhu H, Ueda T,Watanabe-Fukunaga R, et al. (2007) Dissecting eIF4E action in tumorigenesis. Genes Dev 21:3232-3237
47. Willis AE (1999) Translational control of growth factor and protooncogene expression. Int J Biochem Cell Biol 31:73-86
48. Zhang X, Zhao M, Huang AY, Fei Z, Zhang W, Wang XL (2005) The effect of cyclin D expression on cell proliferation in human gliomas. J Clin Neurosci 12:166-168